FibriCheck, a DigitalHealth.London Accelerator alumnus company, announce their Food and Drug Administration (FDA) clearance and the commercial launch of their technology within the US. Their medically certified technology utilises consumer devices and redefines how…
Continue Reading
Hyperfine, a pioneering medical device company, has announced the FDA clearance of its latest software update for the Swoop system, the world’s first FDA-cleared portable magnetic resonance brain imaging device. This ninth-generation AI-powered software…
Continue Reading
What You Should Know:
– AliveCor, the global leader in AI-powered cardiology, today announced that the American Medical Association (AMA) has granted new Category III Current Procedural Terminology (CPT) codes that are applicable to the company’s…
Continue Reading
What You Should Know: – Philips IntelliSite Pathology 5.1 has received 510(k) clearance from the FDA, solidifying its position as the most widely deployed digital pathology solution for primary diagnosis globally. – With over…
Continue Reading
Introduction
Clarius Mobile Health has recently announced that it has obtained U.S. Food and Drug Administration (FDA) clearance for its latest innovation, the Clarius OB AI fetal biometric measurement tool. This development marks a significant…
There is a significant unmet need for effective brain monitoring across various healthcare settings — including emergency departments, intensive care units, outpatient clinics and home environments — due in large part to the persisting…
Continue Reading
What You Should Know:
– Eko Health, a leader in AI-powered early detection of heart and lung diseases, announced today a successful Series D financing round of $41 million.
– This funding, led by ARTIS Ventures,…
Continue Reading
What You Should Know:
– Implicity, a leader in remote patient monitoring and cardiac data management, has received FDA 510(k) clearance for SignalHF1, a groundbreaking new algorithm within their remote monitoring solution.
– SignalHF1 algorithm empowers…
Continue Reading
The demand for home sleep apnea testing (HSAT) devices is escalating, particularly in the context of the coronavirus 2019 (COVID-19) pandemic. The absence of standardized development and verification procedures poses a significant challenge. This…
Continue Reading
What You Should Know:
– RapidAI, a global leader in AI-powered solutions for combating life-threatening vascular diseases, announced today the FDA 510(k) clearance for its innovative AngioFlow™ by RapidAI solution.
– The technology empowers interventional care…
Continue Reading
